AWARD
63 -- Consignment Agreement-Hema Shield Vascular Dacron Grafts
- Notice Date
- 8/21/2009
- Notice Type
- Award Notice
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- Department of Veterans Affairs;South Texas Veterans Health Care System;7400 Merton Minter;San Antonio TX 78229
- ZIP Code
- 78229
- Solicitation Number
- VA-257-09-RQ-0213
- Archive Date
- 9/19/2009
- Point of Contact
- Elaine Perales
- E-Mail Address
-
elaine.perales@va.gov
(elaine.perales@va.gov)
- Small Business Set-Aside
- N/A
- Award Number
- VA257-P-0363
- Award Date
- 8/20/2009
- Awardee
- MAQUET CARDIOVASCULAR US SALES, LLC;45 BARBOUR POND DR;WAYNE;NJ;074702094
- Award Amount
- 0.00
- Description
- August 20, 2009 JUSTIFICATION FOR OTHER THEN FULL AND OPEN COMPETITION IN ACCORDANCE WITH FAR 13.106(b)(2) and 6.302-2(b) 1. The South Texas Veterans Health Care System, Audie L. Murphy Division, has requested a consignment agreement be established with MAQUET Cardiovascular US Sales, LLC to furnish their implantable stents - 51 pieces. Their request to establish a consignment agreement with MAQUET has been agreed upon and approved by appropriate Medical Center Officials. This request is in accordance with FAR 13.501 (a) (2) (ii). 2. The requirement is for the consignment of implantable stents used in the vascular surgery unit for the repair and limb salvage on critical patients. 3. Vascular Surgery has a requested a consignment agreement for implantable stents. Estimated cost for this consignment is $20,790.00 4. In accordance with 10. U.SC. 2304(c)(2), 41 U.S.C. 253(c)(2), Federal Acquisition Regulation (FAR) 13.106-1(b)(2) and 6.302-2(b). 5. These items are used for abdominal, thoracic, and peripheral salvage on critical patients. This request is critical to the veteran patients in the surgical unit. This consignment is critical to the life and longevity of veterans. 6. A Combined Synopsis and Solicitation will not be posted in the Federal Business Opportunity System (BOS), under FAR authority 6.302-2(b), due to the criticality of needed implants for the surgical unit. 7. It is anticipated that the negotiated cost to the Government for this procurement will be fair and reasonable based on historical pricing on other similar type stents. 8. Market research: there were no known contract with the government, and the sales of these services are sold competitively in the commercial marketplace. There are not other companies that were listed when researching the World Wide Web (www) for specific stents. As a result of the market research it was determined that only one company could provide the required items, so in accordance with FAR Part 13.106(b)(2) procurement action was initiated. 9. The veteran patients who are waiting surgery are reliant upon implanted grafts. To alter customer specifications would add additional time to retrain staff on new stents and process. This would also disrupt surgery time and a high risk of veteran's life. MAQUET is a large company, registered in CCR and not on debarred listings. 10. Only one responsible source is intended under authorities of FAR 6.302-2(b) and 13.106(b)(2). 11. I hereby certify that this justification is accurate and complete to the best of my knowledge and belief. //signed//NATHAN PRIETOOR Program Specialist //signed////signe//CHALES TRUMPFHELLERELAINE PERALESContracting Officer Contracting Specialist //signed// - original is signed by individuals listed above.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/VA/VASTHCS/VASTHCS/Awards/VA257-P-0363.html)
- Record
- SN01922597-W 20090823/090822004525-1ca55ec95a43affb8131e7ccfa1b3c81 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |